The effect of sildenafil on quality of life

Annals of Clinical Psychiatry

Volumn 25, Issue 1, 2013, Pages 3-10

  Dording, Christina M ^a   LaRocca, Rachel A ^a   Hails, Katherine A ^a   Vitolo, Ottavio V ^a   Wisniewski, Stephen R ^b   Balasubramani, Goundappa K ^b   Trivedi, Madhukar ^c   Fava, Maurizio ^a   Mischoulon, David ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antidepressant; Libido; Major depressive disorder; Quality of life; Sexual dysfunction; Sildenafil

Indexed keywords

SILDENAFIL;

ADULT; ARTICLE; DRUG EFFECT; FAMILY LIFE; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; LIBIDO; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SEXUAL DYSFUNCTION; SHORT FORM 12; TREATMENT DURATION; WELLBEING;

ADULT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LIBIDO; MALE; MIDDLE AGED; PATIENT PREFERENCE; PHOSPHODIESTERASE 5 INHIBITORS; PIPERAZINES; PURINES; QUALITY OF LIFE; QUESTIONNAIRES; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; SULFONES; TREATMENT OUTCOME;

EID: 84878745511     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Williams VS, Baldwin DS, Hogue SL, et al. Estimating the prevalence and impact of antidepressant-induced sexual dysfunction in 2 European countries: a cross-sectional patient survey. J Clin Psychiatry. 2006;67:204-210. (Pubitemid 43357465)
2. Montejo AL, Llorca G, Izquierdo JA, et al. Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J Clin Psychiatry. 2001;62(suppl 3):10-21. (Pubitemid 32164676)
3. Nurnberg HG, Hensley PL, Gelenberg AJ, et al. Treatment of antidepressant-associated sexual dysfunction with sildenafil: a randomized controlled trial. JAMA. 2003;289:56-64. (Pubitemid 36026278)
4. Rush AJ, Gullion CM, Basco MR, et al. The Inventory of Depressive Symptomatology (IDS): psychometric properties. Psychol Med. 1996;26:477-486. (Pubitemid 26142491)
5. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
6. Endicott J, Nee J, Harrison W, et al. Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure. Psychopharmacol Bull. 1993;29:321-326. (Pubitemid 23311543)
7. Jenkinson C, Layte R. Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy. 1997;2:14-18. (Pubitemid 27077648)
8. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR D report. Am J Psychiatry. 2006;163:1905-1917. (Pubitemid 44807782)
9. Dording, CM, Fisher L, Papakostas G, et al. A double-blind, randomized, pilot dose-finding study of maca root (L. meyenii) for the management of SSRI-induced sexual dysfunction. CNS Neurosci Ther. 2008;14:182-191.
10. Cappelleri JC, Bell SS, Althof SE, et al. Comparison between sildenafil-treated subjects with erectile dysfunction and control subjects on the Self-Esteem and Relationship questionnaire. J Sex Med. 2006;3:274-282.
11. Türk S, Guney I, Altintepe L, et al. Quality of life in male hemodialysis patients. Role of erectile dysfunction. Nephron Clin Pract. 2004;96:c21-c27. (Pubitemid 38456617)
12. Moncada I, Martinex-Jabaloyas JM, Rodriguez-Vela L, et al. Emotional changes in men treated with sildenafil citrate for erectile dysfunction: a double-blind, placebo-controlled clinical trial. J Sex Med. 2009;6:3469-3477.